Guo et al. [280] have shown that high levels of the expression of histone deacetylase 1 correlate with clinical and pathological signs and a negative prognosis in patients with breast cancer, with a direct relationship between HDAC 1 levels and the histone binding protein RBBP4 responsible for tumor cell invasion and migration. Here, HDAC1 is linked to neoplasm.